[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 10, 1913


Author Affiliations

Professor of Therapeutics at Yale Medical School NEW HAVEN, CONN.

JAMA. 1913;60(19):1427-1430. doi:10.1001/jama.1913.04340190021011

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Shall we have the United States Pharmacopeia up to date and of scientific and therapeutic value, or shall it be a book of ancient drug lore intermixed with drugs of real value?

It is now nearly three years since the Pharmacopeial Convention of 1910, and what has been accomplished? Many of the drugs which have been approved have already been announced, and, as it has wisely been determined that a subject of such wide, almost universal, interest as the United States Pharmacopeia should not be made a secret affair—in other words, that its decisions should be public, what follows is not a breach of confidence. The subject, in every detail, is one of public interest, and, therefore, should be of public knowledge.

In this age of exposure of "patent-medicine" frauds, and the age of education as to the danger of some drugs, the uselessness of others, and the limitations of

First Page Preview View Large
First page PDF preview
First page PDF preview